miércoles, 18 de octubre de 2023

From profit to impact: lives saved and the future of RSV vaccine development

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00301-6/fulltext?dgcid=hubspot_update_feature_updatealerts_lanres&utm_campaign=update-lanres&utm_medium=email&_hsmi=278714073&_hsenc=p2ANqtz--us3Vtb9Y2HWjj8FR23uft9oCrUVPuhrGGyrgwXJpPuvMMHYzRRZQmt6wWGFXcfZAIQN4-Ov9IAxPmrRx7ipwmtjuMNw&utm_content=278085462&utm_source=hs_email

No hay comentarios:

Publicar un comentario